Search for: "RANBAXY INC"
Results 61 - 80
of 142
Sorted by Relevance
|
Sort by Date
3 Dec 2006, 10:41 pm
Pfizer shares plunged to about 20 dollars a year ago when Indian drugmaker Ranbaxy Laboratories Inc. said it would produce a generic form of Lipitor. [read post]
16 Apr 2013, 8:30 pm
Ranbaxy Pharm., Inc.,336 F.3d 1322, 1330 (Fed. [read post]
9 Dec 2009, 3:59 pm
Amgen Inc. [read post]
16 Jun 2010, 3:02 pm
Ranbaxy Laboratories Ltd. et al. [read post]
4 Jul 2007, 10:50 pm
If you want to help Duncan in this exciting adventure, email him here with news of the litigation in your jurisdiction.Right: chocks away, as Duncan "Biggles" Bucknell" flies off around the world to service his clientele's international interestsOther scorecards on Duncan's website list the current state of play in the US v Czech Budweiser dispute (here), Ranbaxy's battle with Pfizer over Lipitor (here) and the Eli Lilly/Teva/Dr Reddy's fight over Zyprexa… [read post]
26 Apr 2011, 11:15 pm
Ranbaxy Laboratories manufactured an Accutane version called Sotret which has been withdrawn. [read post]
30 Jun 2011, 9:18 pm
Munsingwear, Inc. that hold that courts should vacate judgments in a case that becomes moot unless the moving party's actions make vacatur inequitable. [read post]
18 Aug 2010, 12:19 am
Ranbaxy Laboratories Ltd. et al. [read post]
15 Aug 2012, 11:02 am
District Court for the District of Columbia by Watson Laboratories, Inc. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
20 Feb 2024, 7:16 am
Pfizer has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India’s Ranbaxy Laboratories to delay sales of less expensive, generic versions of the cholesterol drug Lipitor. [read post]
11 Oct 2010, 12:59 pm
Brooks Brothers, Inc. in which the Court addressed standing under 35 U.S.C. [read post]
18 Feb 2014, 12:43 pm
Genentec, Inc. [read post]
23 Jul 2008, 10:02 am
Hilda Solis (PDF 1.46 MB)Letter Regarding a Proposed Exemption to the PCB Import Ban07/22/2008
Letter to FDA Commissioner Andrew von Eschenbach From House Energy and Commerce Chairman John Dingell and Subcommittee on Oversight and Investigations Chairman Bart Stupak (PDF 1.1 MB)Letter Regarding an Energy and Commerce Investigation Into the Sale of Certain Drugs by Ranbaxy, Inc.07/22/2008
Letter to the President of the United States From the National Governors… [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
19 May 2010, 6:15 am
Immutopics, Inc. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
8 Nov 2007, 9:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [duncanbucknell.com]GlobalIP Think Tank top five's: (IP Think Tank),More on IP law in the virtual world: (VirtualLaw), Interesting times for the Citi brand: (IAM), Velcro has won control of the domain name velcro.biz: (OUT-LAW), The Economic Value of Patent 'Trolls': (IP Think Tank),Industry Trilateral group and the 'global patent application' project: (PatentDocs), Update on the BitTorrent war -… [read post]
16 Jul 2012, 12:10 pm
Ranbaxy Pharma. [read post]
31 Jul 2008, 9:44 pm
", where I discussed some recent generic drug fiascoes discovered by the FDA involving the companies Actavis, ETHEX, and Ranbaxy. [read post]
